Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-145 Cr₹-157 Cr₹-130 Cr₹-105 Cr₹-22 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA is ₹-145 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-145 Cr
Mar2024₹-157 Cr
Mar2023₹-130 Cr
Mar2022₹-105 Cr
Mar2021₹-22 Cr

How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-145 Cr
Negative
Mar2024 ₹-157 Cr
Negative
Mar2023 ₹-130 Cr
Negative
Mar2022 ₹-105 Cr
Negative
Mar2021 ₹-22 Cr -

Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹18,376.2 Cr -0.3% -16.8% -34.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,470.0 Cr -0.3% 3.1% 2.2% Stock Analytics
DIVIS LABORATORIES ₹161,996.0 Cr 0.5% -2.9% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,440.0 Cr 0.1% 1.4% 37.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,417.0 Cr 1.9% 1.4% 10.7% Stock Analytics
CIPLA ₹101,445.0 Cr -3.3% -6.9% -17% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-0.3%

-16.8%

-34.1%

SENSEX

-0%

-10.7%

1%


You may also like the below Video Courses